Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate T Simms

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Cytopathology|May 3, 2019
Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programsMegan A Smith, Julia M L Brotherton, Ian G Hammond, et al.
Plos Medicine|March 11, 2021
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysisJane J Kim, Kate T Simms, James Killen, et al.
Plos One|January 18, 2017
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaKate T Simms, Michaela Hall, Megan A Smith, et al.
The Lancet. Oncology|February 24, 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling studyKate T Simms, Julia Steinberg, Michael Caruana, et al.
The Lancet. Public Health|October 7, 2018
The projected timeframe until cervical cancer elimination in Australia: a modelling studyMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
The Lancet. Oncology|May 3, 2019
Towards global elimination of cervical cancer in all groups of women - Authors' replyKate T Simms, Julia Steinberg, Michael Caruana, et al.
Plos One|October 2, 2019
Development and application of a framework to estimate health care costs in China: The cervical cancer exampleYi-Jun Liu, Adam Keane, Kate T Simms, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 2020
Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled AnalysisMegan A Smith, Michaela T Hall, Marion Saville, et al.
Public Health Research & Practice|August 7, 2019
Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimatesJie-Bin Lew, Eleanor Feletto, Stephen Wade, et al.
The Lancet. Public Health|December 19, 2017
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening ProgramJie-Bin Lew, Kate T Simms, Megan A Smith, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Cytopathology|May 3, 2019
Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programsMegan A Smith, Julia M L Brotherton, Ian G Hammond, et al.
Plos Medicine|March 11, 2021
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysisJane J Kim, Kate T Simms, James Killen, et al.
Plos One|January 18, 2017
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaKate T Simms, Michaela Hall, Megan A Smith, et al.
The Lancet. Oncology|February 24, 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling studyKate T Simms, Julia Steinberg, Michael Caruana, et al.
The Lancet. Public Health|October 7, 2018
The projected timeframe until cervical cancer elimination in Australia: a modelling studyMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
The Lancet. Oncology|May 3, 2019
Towards global elimination of cervical cancer in all groups of women - Authors' replyKate T Simms, Julia Steinberg, Michael Caruana, et al.
Plos One|October 2, 2019
Development and application of a framework to estimate health care costs in China: The cervical cancer exampleYi-Jun Liu, Adam Keane, Kate T Simms, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 2020
Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled AnalysisMegan A Smith, Michaela T Hall, Marion Saville, et al.
Public Health Research & Practice|August 7, 2019
Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimatesJie-Bin Lew, Eleanor Feletto, Stephen Wade, et al.
The Lancet. Public Health|December 19, 2017
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening ProgramJie-Bin Lew, Kate T Simms, Megan A Smith, et al.
Pageof 4